[go: up one dir, main page]

AU2006259124A8 - Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors - Google Patents

Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors

Info

Publication number
AU2006259124A8
AU2006259124A8 AU2006259124A AU2006259124A AU2006259124A8 AU 2006259124 A8 AU2006259124 A8 AU 2006259124A8 AU 2006259124 A AU2006259124 A AU 2006259124A AU 2006259124 A AU2006259124 A AU 2006259124A AU 2006259124 A8 AU2006259124 A8 AU 2006259124A8
Authority
AU
Australia
Prior art keywords
imidaznaphthyridine
spiro
derivatives
gastric acid
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006259124A
Other versions
AU2006259124A1 (en
Inventor
Christof Brehm
Wilm Buhr
Maria Vittoria Chiesa
Wolfgang Kromer
Andreas Palmer
Stefan Postius
Joerg Senn-Bilfinger
Wolfgang-Alexander Simon
Peter Jan Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Nycomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed GmbH filed Critical Nycomed GmbH
Publication of AU2006259124A1 publication Critical patent/AU2006259124A1/en
Publication of AU2006259124A8 publication Critical patent/AU2006259124A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2006259124A 2005-06-16 2006-06-13 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors Abandoned AU2006259124A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105327.0 2005-06-16
EP05105327 2005-06-16
PCT/EP2006/063164 WO2006134112A1 (en) 2005-06-16 2006-06-13 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors

Publications (2)

Publication Number Publication Date
AU2006259124A1 AU2006259124A1 (en) 2006-12-21
AU2006259124A8 true AU2006259124A8 (en) 2008-04-03

Family

ID=34940190

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006259124A Abandoned AU2006259124A1 (en) 2005-06-16 2006-06-13 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors

Country Status (7)

Country Link
EP (1) EP1899341A1 (en)
JP (1) JP2008543809A (en)
AR (1) AR054772A1 (en)
AU (1) AU2006259124A1 (en)
CA (1) CA2610920A1 (en)
TW (1) TW200716637A (en)
WO (1) WO2006134112A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
CA2452803A1 (en) * 2001-08-10 2003-02-20 Altana Pharma Ag Tricyclic imidazopyridines

Also Published As

Publication number Publication date
AU2006259124A1 (en) 2006-12-21
TW200716637A (en) 2007-05-01
JP2008543809A (en) 2008-12-04
EP1899341A1 (en) 2008-03-19
WO2006134112A1 (en) 2006-12-21
CA2610920A1 (en) 2006-12-21
AR054772A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
ZA200700181B (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
ZA200709745B (en) Compositions and methods for inhibiting gastric acid secretion
ZA200802488B (en) 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
IL185399A0 (en) Pyridyl acetic acid compounds
EP2078001B8 (en) Diazepane-acetamide derivatives as selective 11 -hsd1 inhibitors
EP1976532A4 (en) Fast acting inhibitor of gastric acid secretion
AU2007312310A1 (en) Phenylacetamides useful as protein kinase inhibitors
IL183599A0 (en) Novel hydantoin derivatives as metalloproteinase inhibitors
ZA200705076B (en) Novel hydantoin derivatives as metalloproteinase inhibitors
IL185790A0 (en) Amino acid derivatives
ZA200709852B (en) Spiro-benzimidazoles as inhibitors of gastric acid secretion
GB0624963D0 (en) Derivatives of 188-Glycyrrhetinic Acid
GB0602780D0 (en) Amino Acid Derivatives
AU2006259124A8 (en) Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors
ZA200710338B (en) Oxydiazole derivatives as DGAT inhibitors
HK1144200A (en) Pyrazolo-pyrazines derivatives used as g protein inhibitors
HK1114847A (en) Pyridyl acetic acid compounds
HK1106244A (en) Novel hydantoin derivatives as metalloproteinase inhibitors
HK1128682A (en) 4-substituted phenoxyphenylacetic acid derivatives
HK1115121A (en) NOVEL HETEROCYCLIC NF-κB INHIBITORS
HK1126492A (en) Novel heterocyclic compounds
AP2006003847A0 (en) Benzhimidazolone carboxylic acid derivatives
HK1117837A (en) Oxadiazole derivatives as dgat inhibitors
HK1090927A (en) Pyrazolotriazines as kinase inhibitors

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE CO-INVENTORS TO READ SENN-BILFINGER, JOERG

TH Corrigenda

Free format text: IN VOL 22, NO 5, PAGE(S) 479 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE -NAME INDEX UNDER THE NAME ALTANA PHARMA AG, APPLICATION NO. 2006259124, UNDER INID (71) CORRECT THE NAME TO NYCOMED GMBH

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period